Mark G. Lebwohl

Last updated
Mark G. Lebwohl
NationalityAmerican
Education Columbia University
Harvard Medical School
Years active1983-present
Known for psoriasis
pseudoxanthoma elasticum
Medical career
Profession dermatologist
Institutions The Mount Sinai Hospital

Mark G. Lebwohl is an American dermatologist and author who is Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology and the Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai in New York City. [1] [2]

Contents

Lebwohl's books include the book on dermatologic therapy, Treatment of Skin Disease ( ISBN   0323036031), as well as Atlas of the Skin and Systemic Disease ( ISBN   044306539X). He has authored more than 500 publications, [3] [4] multiple book chapters and has been named as one of New York Magazine’s “Best Doctors” every year since the inception of the annual list. [5] [6] Dr. Brian S. Kim is director of a Center for Neuroinflammation and Sensation named in Mark Lebwohl's honor at Icahn School of Medicine at Mount Sinai.

Biography

Education

Lebwohl graduated from Columbia University in 1974. He earned his medical degree from Harvard Medical School in 1978 and subsequently completed residencies in both internal medicine and dermatology at the Icahn School of Medicine at Mount Sinai. [4]

Career

In 1983, he was made assistant professor of dermatology at Mount Sinai. In 1997, he was named Chairman of the Department [3] which, under his leadership, has been at the forefront of the management of psoriasis. [7]

Lebwohl was the first to report the cardiac complications of pseudoxanthoma elasticum, and, additionally, he has developed new techniques for diagnosing the disease. [7] He was also the first to use immunomodulators (imiquimod) to treat precancerous skin lesions; [8] [9] the first to use topical calcineurin inhibitors to treat psoriasis; [10] and the first to identify interactions between topical vitamin D analogues such as calcipotriol and calcitriol with other topical medications and with ultraviolet light. [11] [12] [13]

Memberships

Lebwohl has served as president of the New York Dermatological Society, the Manhattan Dermatologic Society, and the New York State Society of Dermatology, and as chairman of the Dermatology Section of the New York Academy of Medicine. He served as chairman of the National Psoriasis Foundation's medical board [14] chairman of the Psoriasis Task Force of the American Academy of Dermatology (AAD) and was a member of the Scientific Assembly Council. He chaired the academy's summer meeting in 2001 in California and the AAD annual meeting in Washington, D.C. in 2004. He was elected to the Board of Directors of the AAD for 2010–2014. In 2020, he was elected to the board of the American Skin Association. [15] [16]

Awards and honors

Lebwohl earned Presidential Citations in 2002, 2005 and 2006 from the American Academy of Dermatology. [17] Additional awards include:

Publications

Journals

Lebwohl is on the editorial board of the Journal of the American Academy of Dermatology and was the editor of the Dermatology Section of Scientific American Medicine, now called ACP Medicine. He is a founding editor of Psoriasis Forum and was medical editor of the bulletin of the National Psoriasis Foundation, Psoriasis Advance. [13] [22] [23]

Books

Publications

Partial list:

Related Research Articles

<span class="mw-page-title-main">Psoriasis</span> Skin disease

Psoriasis is a long-lasting, noncontagious autoimmune disease characterized by patches of abnormal skin. These areas are red, pink, or purple, dry, itchy, and scaly. Psoriasis varies in severity from small localized patches to complete body coverage. Injury to the skin can trigger psoriatic skin changes at that spot, which is known as the Koebner phenomenon.

<span class="mw-page-title-main">Acanthosis nigricans</span> Medical condition

Acanthosis nigricans is a medical sign characterised by brown-to-black, poorly defined, velvety hyperpigmentation of the skin. It is usually found in body folds, such as the posterior and lateral folds of the neck, the armpits, groin, navel, forehead and other areas.

<span class="mw-page-title-main">Pimecrolimus</span> Chemical compound

Pimecrolimus is an immunomodulating agent of the calcineurin inhibitor class used in the treatment of atopic dermatitis (eczema). It is available as a topical cream, once marketed by Novartis under the trade name Elidel.

Antipruritics, abirritants, or anti-itch drugs, are medications that inhibit the itching often associated with sunburns, allergic reactions, eczema, psoriasis, chickenpox, fungal infections, insect bites and stings like those from mosquitoes, fleas, and mites, and contact dermatitis and urticaria caused by plants such as poison ivy or stinging nettle. It can also be caused by chronic kidney disease and related conditions.

<span class="mw-page-title-main">Pityriasis rosea</span> Skin disease

Pityriasis rosea is a type of skin rash. Classically, it begins with a single red and slightly scaly area known as a "herald patch". This is then followed, days to weeks later, by an eruption of many smaller scaly spots; pinkish with a red edge in people with light skin and greyish in darker skin. About 20% of cases show atypical deviations from this pattern. It usually lasts less than three months and goes away without treatment. Sometimes malaise or a fever may occur before the start of the rash or itchiness, but often there are few other symptoms.

Psychodermatology is the treatment of skin disorders using psychological and psychiatric techniques by addressing the interaction between mind and skin. Though historically there has not been strong scientific support for its practice, there is increasing evidence that behavioral treatments may be effective in the management of chronic skin disorders.

Dermatoses of pregnancy are the inflammatory skin diseases that are specific to women while they are pregnant. While some use the term 'polymorphic eruption of pregnancy' to cover these, this term is a synonym used in the UK for Pruritic urticarial papules and plaques of pregnancy, which is the commonest of these skin conditions.

<span class="mw-page-title-main">Transient acantholytic dermatosis</span> Medical condition

Grover's disease (GD) is a polymorphic, pruritic, papulovesicular dermatosis characterized histologically by acantholysis with or without dyskeratosis. Once confirmed, most cases of Grover's disease last six to twelve months, which is why it was originally called "transient". However it may last much longer. Nevertheless, it is not to be confused with relapsing linear acantholytic dermatosis.

The matchbox sign, also referred to as the Ziploc bag sign or the specimen sign, is a psychiatric medical sign in which a patient arrives at a doctor's office with items extracted from the skin; these items are intended to serve as proof of a parasitic infestation, and are typically stored in a small container such as a matchbox. 50–80% of patients with delusional parasitosis present with this sign.

<span class="mw-page-title-main">Parakeratosis</span>

Parakeratosis is a mode of keratinization characterized by the retention of nuclei in the stratum corneum. In mucous membranes, parakeratosis is normal. In the skin, this process leads to the abnormal replacement of annular squames with nucleated cells. Parakeratosis is associated with the thinning or loss of the granular layer and is usually seen in diseases of increased cell turnover, whether inflammatory or neoplastic. Parakeratosis is seen in the plaques of psoriasis and in dandruff.

<span class="mw-page-title-main">Psoriatic onychodystrophy</span> Medical condition

Psoriatic onychodystrophy or psoriatic nails is a nail disease. It is common in those with psoriasis, with reported incidences varying from 10% to 78%. Elderly patients and those with psoriatic arthritis are more likely to have psoriatic nails.

Large plaque parapsoriasis are skin lesions that may be included in the modern scheme of cutaneous conditions described as parapsoriasis. These lesions, called plaques, may be irregularly round-shaped to oval and are 10 cm (4 in) or larger in diameter. They can be very thin plaques that are asymptomatic or mildly pruritic. Large-plaque parapsoriasis is a common associate of retiform parapsoriasis, can be accompanied by poikiloderma vasculare atrophicans, and can in rare occasions be a precursor to cutaneous T-cell lymphoma.

Ectodermal dysplasia with corkscrew hairs is a skin condition with salient features including exaggerated pili torti, scalp keloids, follicular plugging, keratosis pilaris, xerosis, eczema, palmoplantar keratoderma, syndactyly, onychodysplasia and conjunctival neovascularization.

Lepidopterism is an irritant contact dermatitis caused by irritating caterpillar or moth hairs coming into contact with the skin or mucosa. When referring to the cause, moth dermatitis and caterpillar dermatitis are commonly used; Caripito itch is an older name referring to the moth dermatitis caused by some Hylesia species.

Goeckerman therapy is a regimen for treatment of moderate to severe plaque psoriasis using a combination of crude coal tar and artificial ultraviolet radiation. It is a specialized form of light therapy.

Brian V. Jegasothy was a dermatologist and visiting professor at over 50 Universities. and clinics, and was the Chairman of the Department of Dermatology at the University of Pittsburgh from 1987 to 1999.

Brian S. Kim is the Sol and Clara Kest Professor, Vice Chair of Research, and Site Chair of Mount Sinai West and Morningside in the Kimberly and Eric J. Waldman Department of Dermatology at Icahn School of Medicine at Mount Sinai. He is also Director of the Mark Lebwohl Center for Neuroinflammation and Sensation.

<span class="mw-page-title-main">Tapinarof</span> Chemical compound

Tapinarof, also known as benvitimod and sold under the brand name Vtama, is a medication used for the treatment of plaque psoriasis. The medication is applied to the skin. Besides its use in medicine, tapinarof is a naturally occurring compound found in bacterial symbionts of nematodes which has antibiotic properties.

Joel M. Gelfand is an American dermatologist and epidemiologist at the University of Pennsylvania in Philadelphia, Pennsylvania. He currently serves as the James J. Leyden Professor in Clinical Investigation, the Vice Chair of Clinical Research, the director of the Psoriasis and Phototherapy Treatment Center, and the medical director of the Clinical Studies Unit in the Department of Dermatology at the Perelman School of Medicine at the University of Pennsylvania. He studies systemic comorbidities of psoriasis and much of his research has centered on the connection between cardiovascular disease and psoriasis.

Aditya Kumar Gupta is a Canadian academic and distinguished professor at the University of Toronto. He is also a Fellow of the American Academy of Dermatology, the Royal College of Physicians and Surgeons of Canada, and the European Confederation of Medical Mycology.

References

  1. ↑ Lebwohl, Mark G.; Heymann, Warren R.; Berth-Jones, John; Coulson, Ian (2017-09-19). Treatment of Skin Disease E-Book: Comprehensive Therapeutic Strategies. Elsevier Health Sciences. ISBN   978-0-7020-6913-0.
  2. ↑ "Mark Lebwohl". Mount Sinai. Retrieved May 15, 2020.
  3. 1 2 TheDerm.org – Editorial Board and Advisors
  4. 1 2 "Mark Lebwohl, MD - American Osteopathic College of Dermatology (AOCD)". www.aocd.org. Retrieved 2020-05-16.
  5. ↑ New York Magazine Best Doctors 2009
  6. ↑ American Registry
  7. 1 2 Aufses Jr., Arthur H; Barbara Niss (2002). This House of Noble Deeds . NYU Press. pp.  197–198. ISBN   0-8147-0500-6.
  8. ↑ Persaud AN, Shamuelova E, Sherer D, Lou W, Singer G, Cervera C, et al. (2002). "Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis". J Am Acad Dermatol. 47 (4): 553–6. doi:10.1067/mjd.2002.123492. PMID   12271300.
  9. ↑ Lebwohl M, Dinehart S, Whiting D, Lee PK, Tawfik N, Jorizzo J, et al. (2004). "Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials". J Am Acad Dermatol. 50 (5): 714–21. doi:10.1016/j.jaad.2003.12.010. PMID   15097955.
  10. ↑ Lebwohl M, Freeman AK, Chapman MS, Feldman SR, Hartle JE, Henning A, et al. (2004). "Tacrolimus ointment is effective for facial and intertriginous psoriasis". J Am Acad Dermatol. 51 (5): 723–30. doi:10.1016/j.jaad.2004.07.011. PMID   15523350.
  11. ↑ Patel B, Siskin S, Krazmien R, Lebwohl M (1998). "Compatibility of calcipotriene with other topical medications". J Am Acad Dermatol. 38 (6 Pt 1): 1010–1. doi:10.1016/s0190-9622(98)70171-9. PMID   9632021.
  12. ↑ Lebwohl M, Hecker D, Martinez J, Sapadin A, Patel B (1997). "Interactions between calcipotriene and ultraviolet light". J Am Acad Dermatol. 37 (1): 93–5. doi:10.1016/s0190-9622(97)70217-2. PMID   9216529.
  13. 1 2 "2020 Real World Dermatology for Residents - Board Immersion". www.cvent.com. Retrieved 2020-05-16.
  14. ↑ Suddenly, skin creams cost way more - HT Health
  15. ↑ "American Skin Association Announces New Board Member Mark Lebwohl, MD". P&T Community. 2020-04-27. Retrieved 2020-05-16.
  16. ↑ "News American Skin Association". www.americanskin.org. Retrieved 2020-05-16.
  17. ↑ "Dermira's Co-founder and Chief Medical Officer, Eugene A. Bauer, M.D., Receives Presidential Citation from the American Academy of Dermatology". investor.dermira.com. Retrieved 2020-05-16.
  18. ↑ "National Psoriasis Foundation honors Dr. Mark G. Lebwohl, renowned dermatologist and psoriasis expert | National Psoriasis Foundation". www.psoriasis.org. Retrieved 2020-05-16.
  19. ↑ "People § The Dermatology Summit". www.dermsummit.com. Retrieved 2020-05-16.
  20. ↑ British Medical Association Medical Books Archived 2015-06-07 at the Wayback Machine
  21. ↑ Society of Authors
  22. ↑ WebMD
  23. ↑ Business Week
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.